Accelerated partial-breast irradiation is not statistically equivalent to whole-breast irradiation in local tumor control, NRG oncology trial shows

Dian Wang, William Tseng, Brian Van Tine appointed to new Sarcoma Subcommittee at NRG Oncology; Clifton Fuller named vice chair of Imaging Committee

Dian Wang, William Tseng, and Brian A. Van Tine were appointed to NRG Oncology’s newly formed Sarcoma Subcommittee. Clifton (Dave) Fuller was named vice chair for NRG’s Imaging Committee.

April 11, 2025

Vol.51 No.14

In Brief

Less Radical, a podcast about Bernie Fisher, nominated for two Webby Awards

Less Radical, a documentary podcast that tells story of Bernie Fisher, a pioneering surgeon-scientist who redefined breast cancer treatment, was nominated for Best Podcast - Documentary and Best Indie Podcast – Limited Run in the 29th Annual Webby Awards.

April 04, 2025

Vol.51 No.13

Clinical Roundup

Mass General study: Screenings for breast and colorectal cancer 4x higher than lung cancer

Although lung cancer screening is recommended in the U.S. for certain individuals with a history of smoking, only 18% of eligible individuals in the U.S. get screened.

April 04, 2025

Vol.51 No.13

Clinical Roundup

Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer, Baylor Medicine study finds

A study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer to develop resistance to therapy. Researchers at Baylor College of Medicine showed that lipid accumulation in tumor cells and nearby immune cells promotes immune suppression, but disrupting lipid formulation reverses treatment resistance and the immunosuppressive microenvironment.

April 04, 2025

Vol.51 No.13

In the Archives

Breast cancer activists in the 90s got DOD to fund cancer research—now that program has been gutted

In 1991, the National Breast Cancer Coalition demanded that the federal government spend $300 million more on breast cancer research. This push resulted in the creation of the Department of Defense Congressionally Directed Medical Research Program, which has broadened to 34 other diseases with an FY24 budget of $1.5 billion.

March 28, 2025

Vol.51 No.12

In Brief

Walter Curran, Jr. named Whitaker Endowed Chief of Piedmont Oncology

Walter J. “Wally” Curran, Jr. has been named the Whitaker Endowed Chief of Piedmont Oncology. This bestowed title is supported by the Piedmont Foundation’s Whitaker Endowment, a fund created by the Atlanta community in tribute to Piedmont’s cancer surgical leader, William Whitaker.

March 28, 2025

Vol.51 No.12

Accelerated partial-breast irradiation is not statistically equivalent to whole-breast irradiation in local tumor control, NRG oncology trial shows

YOU MAY BE INTERESTED IN

Dian Wang, William Tseng, Brian Van Tine appointed to new Sarcoma Subcommittee at NRG Oncology; Clifton Fuller named vice chair of Imaging Committee

Less Radical, a podcast about Bernie Fisher, nominated for two Webby Awards

Mass General study: Screenings for breast and colorectal cancer 4x higher than lung cancer

Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer, Baylor Medicine study finds

Breast cancer activists in the 90s got DOD to fund cancer research—now that program has been gutted

Walter Curran, Jr. named Whitaker Endowed Chief of Piedmont Oncology

Renew today!

Subscriber content